世界の中等度～重度にきび治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Moderate To Severe Acne Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4512
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、100ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、中等度～重度にきび治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ホルモン療法、薬物療法、光線力学療法、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・中等度～重度にきび治療薬の市場動向
・企業の競争状況、市場シェア
・中等度～重度にきび治療薬の種類別市場規模と予測2016-2027（ホルモン療法、薬物療法、光線力学療法、その他）
・中等度～重度にきび治療薬の用途別市場規模と予測2016-2027（病院、クリニック、その他）
・中等度～重度にきび治療薬の北米市場規模2016-2027（アメリカ、カナダ）
・中等度～重度にきび治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・中等度～重度にきび治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・中等度～重度にきび治療薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・中等度～重度にきび治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Allergan、Bausch Health、Cipher Pharmaceuticals、Bayer、Pfizer、Novartis）
・結論

Acne Vulgaris is listed as one of the most common inflammatory disease among different types of skin disorders.

Market Analysis and Insights: Global Moderate To Severe Acne Therapeutics Market
The global Moderate To Severe Acne Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Moderate To Severe Acne Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Moderate To Severe Acne Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Moderate To Severe Acne Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Moderate To Severe Acne Therapeutics market.

Global Moderate To Severe Acne Therapeutics Scope and Market Size
Moderate To Severe Acne Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Moderate To Severe Acne Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Hormonal Therapy
Drug Therapy
Photodynamic Therapy
Others

Segment by Application
Hospital
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Allergan
Bausch Health
Cipher Pharmaceuticals
Bayer
Pfizer
Novartis

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Moderate To Severe Acne Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Hormonal Therapy
1.2.3 Drug Therapy
1.2.4 Photodynamic Therapy
1.2.5 Others
1.3 Market by Application
1.3.1 Global Moderate To Severe Acne Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Moderate To Severe Acne Therapeutics Market Perspective (2016-2027)
2.2 Moderate To Severe Acne Therapeutics Growth Trends by Regions
2.2.1 Moderate To Severe Acne Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Moderate To Severe Acne Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Moderate To Severe Acne Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Moderate To Severe Acne Therapeutics Industry Dynamic
2.3.1 Moderate To Severe Acne Therapeutics Market Trends
2.3.2 Moderate To Severe Acne Therapeutics Market Drivers
2.3.3 Moderate To Severe Acne Therapeutics Market Challenges
2.3.4 Moderate To Severe Acne Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Moderate To Severe Acne Therapeutics Players by Revenue
3.1.1 Global Top Moderate To Severe Acne Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Moderate To Severe Acne Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Moderate To Severe Acne Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Moderate To Severe Acne Therapeutics Revenue
3.4 Global Moderate To Severe Acne Therapeutics Market Concentration Ratio
3.4.1 Global Moderate To Severe Acne Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Moderate To Severe Acne Therapeutics Revenue in 2020
3.5 Moderate To Severe Acne Therapeutics Key Players Head office and Area Served
3.6 Key Players Moderate To Severe Acne Therapeutics Product Solution and Service
3.7 Date of Enter into Moderate To Severe Acne Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Moderate To Severe Acne Therapeutics Breakdown Data by Type
4.1 Global Moderate To Severe Acne Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Moderate To Severe Acne Therapeutics Forecasted Market Size by Type (2022-2027)

5 Moderate To Severe Acne Therapeutics Breakdown Data by Application
5.1 Global Moderate To Severe Acne Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Moderate To Severe Acne Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Moderate To Severe Acne Therapeutics Market Size (2016-2027)
6.2 North America Moderate To Severe Acne Therapeutics Market Size by Type
6.2.1 North America Moderate To Severe Acne Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Moderate To Severe Acne Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Moderate To Severe Acne Therapeutics Market Size by Type (2016-2027)
6.3 North America Moderate To Severe Acne Therapeutics Market Size by Application
6.3.1 North America Moderate To Severe Acne Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Moderate To Severe Acne Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Moderate To Severe Acne Therapeutics Market Size by Application (2016-2027)
6.4 North America Moderate To Severe Acne Therapeutics Market Size by Country
6.4.1 North America Moderate To Severe Acne Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Moderate To Severe Acne Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Moderate To Severe Acne Therapeutics Market Size (2016-2027)
7.2 Europe Moderate To Severe Acne Therapeutics Market Size by Type
7.2.1 Europe Moderate To Severe Acne Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Moderate To Severe Acne Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Moderate To Severe Acne Therapeutics Market Size by Type (2016-2027)
7.3 Europe Moderate To Severe Acne Therapeutics Market Size by Application
7.3.1 Europe Moderate To Severe Acne Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Moderate To Severe Acne Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Moderate To Severe Acne Therapeutics Market Size by Application (2016-2027)
7.4 Europe Moderate To Severe Acne Therapeutics Market Size by Country
7.4.1 Europe Moderate To Severe Acne Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Moderate To Severe Acne Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Moderate To Severe Acne Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Moderate To Severe Acne Therapeutics Market Size by Type
8.2.1 Asia-Pacific Moderate To Severe Acne Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Moderate To Severe Acne Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Moderate To Severe Acne Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Moderate To Severe Acne Therapeutics Market Size by Application
8.3.1 Asia-Pacific Moderate To Severe Acne Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Moderate To Severe Acne Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Moderate To Severe Acne Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Moderate To Severe Acne Therapeutics Market Size by Region
8.4.1 Asia-Pacific Moderate To Severe Acne Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Moderate To Severe Acne Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Moderate To Severe Acne Therapeutics Market Size (2016-2027)
9.2 Latin America Moderate To Severe Acne Therapeutics Market Size by Type
9.2.1 Latin America Moderate To Severe Acne Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Moderate To Severe Acne Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Moderate To Severe Acne Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Moderate To Severe Acne Therapeutics Market Size by Application
9.3.1 Latin America Moderate To Severe Acne Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Moderate To Severe Acne Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Moderate To Severe Acne Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Moderate To Severe Acne Therapeutics Market Size by Country
9.4.1 Latin America Moderate To Severe Acne Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Moderate To Severe Acne Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Moderate To Severe Acne Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Moderate To Severe Acne Therapeutics Market Size by Type
10.2.1 Middle East & Africa Moderate To Severe Acne Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Moderate To Severe Acne Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Moderate To Severe Acne Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Moderate To Severe Acne Therapeutics Market Size by Application
10.3.1 Middle East & Africa Moderate To Severe Acne Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Moderate To Severe Acne Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Moderate To Severe Acne Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Moderate To Severe Acne Therapeutics Market Size by Country
10.4.1 Middle East & Africa Moderate To Severe Acne Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Moderate To Severe Acne Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Allergan Business Overview
11.1.3 Allergan Moderate To Severe Acne Therapeutics Introduction
11.1.4 Allergan Revenue in Moderate To Severe Acne Therapeutics Business (2016-2021)
11.1.5 Allergan Recent Development
11.2 Bausch Health
11.2.1 Bausch Health Company Details
11.2.2 Bausch Health Business Overview
11.2.3 Bausch Health Moderate To Severe Acne Therapeutics Introduction
11.2.4 Bausch Health Revenue in Moderate To Severe Acne Therapeutics Business (2016-2021)
11.2.5 Bausch Health Recent Development
11.3 Cipher Pharmaceuticals
11.3.1 Cipher Pharmaceuticals Company Details
11.3.2 Cipher Pharmaceuticals Business Overview
11.3.3 Cipher Pharmaceuticals Moderate To Severe Acne Therapeutics Introduction
11.3.4 Cipher Pharmaceuticals Revenue in Moderate To Severe Acne Therapeutics Business (2016-2021)
11.3.5 Cipher Pharmaceuticals Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Moderate To Severe Acne Therapeutics Introduction
11.4.4 Bayer Revenue in Moderate To Severe Acne Therapeutics Business (2016-2021)
11.4.5 Bayer Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Moderate To Severe Acne Therapeutics Introduction
11.5.4 Pfizer Revenue in Moderate To Severe Acne Therapeutics Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Moderate To Severe Acne Therapeutics Introduction
11.6.4 Novartis Revenue in Moderate To Severe Acne Therapeutics Business (2016-2021)
11.6.5 Novartis Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Moderate To Severe Acne Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Hormonal Therapy
Table 3. Key Players of Drug Therapy
Table 4. Key Players of Photodynamic Therapy
Table 5. Key Players of Others
Table 6. Global Moderate To Severe Acne Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Moderate To Severe Acne Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Moderate To Severe Acne Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Moderate To Severe Acne Therapeutics Market Share by Regions (2016-2021)
Table 10. Global Moderate To Severe Acne Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Moderate To Severe Acne Therapeutics Market Share by Regions (2022-2027)
Table 12. Moderate To Severe Acne Therapeutics Market Trends
Table 13. Moderate To Severe Acne Therapeutics Market Drivers
Table 14. Moderate To Severe Acne Therapeutics Market Challenges
Table 15. Moderate To Severe Acne Therapeutics Market Restraints
Table 16. Global Moderate To Severe Acne Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Moderate To Severe Acne Therapeutics Market Share by Players (2016-2021)
Table 18. Global Top Moderate To Severe Acne Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Moderate To Severe Acne Therapeutics as of 2020)
Table 19. Ranking of Global Top Moderate To Severe Acne Therapeutics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Moderate To Severe Acne Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Moderate To Severe Acne Therapeutics Product Solution and Service
Table 23. Date of Enter into Moderate To Severe Acne Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Moderate To Severe Acne Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Moderate To Severe Acne Therapeutics Revenue Market Share by Type (2016-2021)
Table 27. Global Moderate To Severe Acne Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Moderate To Severe Acne Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Moderate To Severe Acne Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Moderate To Severe Acne Therapeutics Revenue Market Share by Application (2016-2021)
Table 31. Global Moderate To Severe Acne Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Moderate To Severe Acne Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Moderate To Severe Acne Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Moderate To Severe Acne Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Moderate To Severe Acne Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Moderate To Severe Acne Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Moderate To Severe Acne Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Moderate To Severe Acne Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Moderate To Severe Acne Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Moderate To Severe Acne Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Moderate To Severe Acne Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Moderate To Severe Acne Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Moderate To Severe Acne Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Moderate To Severe Acne Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Moderate To Severe Acne Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Moderate To Severe Acne Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Moderate To Severe Acne Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Moderate To Severe Acne Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Moderate To Severe Acne Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Moderate To Severe Acne Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Moderate To Severe Acne Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Moderate To Severe Acne Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Moderate To Severe Acne Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Moderate To Severe Acne Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Moderate To Severe Acne Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Moderate To Severe Acne Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Moderate To Severe Acne Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Moderate To Severe Acne Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Moderate To Severe Acne Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Moderate To Severe Acne Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Moderate To Severe Acne Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Moderate To Severe Acne Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Allergan Company Details
Table 64. Allergan Business Overview
Table 65. Allergan Moderate To Severe Acne Therapeutics Product
Table 66. Allergan Revenue in Moderate To Severe Acne Therapeutics Business (2016-2021) & (US$ Million)
Table 67. Allergan Recent Development
Table 68. Bausch Health Company Details
Table 69. Bausch Health Business Overview
Table 70. Bausch Health Moderate To Severe Acne Therapeutics Product
Table 71. Bausch Health Revenue in Moderate To Severe Acne Therapeutics Business (2016-2021) & (US$ Million)
Table 72. Bausch Health Recent Development
Table 73. Cipher Pharmaceuticals Company Details
Table 74. Cipher Pharmaceuticals Business Overview
Table 75. Cipher Pharmaceuticals Moderate To Severe Acne Therapeutics Product
Table 76. Cipher Pharmaceuticals Revenue in Moderate To Severe Acne Therapeutics Business (2016-2021) & (US$ Million)
Table 77. Cipher Pharmaceuticals Recent Development
Table 78. Bayer Company Details
Table 79. Bayer Business Overview
Table 80. Bayer Moderate To Severe Acne Therapeutics Product
Table 81. Bayer Revenue in Moderate To Severe Acne Therapeutics Business (2016-2021) & (US$ Million)
Table 82. Bayer Recent Development
Table 83. Pfizer Company Details
Table 84. Pfizer Business Overview
Table 85. Pfizer Moderate To Severe Acne Therapeutics Product
Table 86. Pfizer Revenue in Moderate To Severe Acne Therapeutics Business (2016-2021) & (US$ Million)
Table 87. Pfizer Recent Development
Table 88. Novartis Company Details
Table 89. Novartis Business Overview
Table 90. Novartis Moderate To Severe Acne Therapeutics Product
Table 91. Novartis Revenue in Moderate To Severe Acne Therapeutics Business (2016-2021) & (US$ Million)
Table 92. Novartis Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Moderate To Severe Acne Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Hormonal Therapy Features
Figure 3. Drug Therapy Features
Figure 4. Photodynamic Therapy Features
Figure 5. Others Features
Figure 6. Global Moderate To Severe Acne Therapeutics Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Moderate To Severe Acne Therapeutics Report Years Considered
Figure 11. Global Moderate To Severe Acne Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Moderate To Severe Acne Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Moderate To Severe Acne Therapeutics Market Share by Regions: 2020 VS 2027
Figure 14. Global Moderate To Severe Acne Therapeutics Market Share by Regions (2022-2027)
Figure 15. Global Moderate To Severe Acne Therapeutics Market Share by Players in 2020
Figure 16. Global Top Moderate To Severe Acne Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Moderate To Severe Acne Therapeutics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Moderate To Severe Acne Therapeutics Revenue in 2020
Figure 18. Global Moderate To Severe Acne Therapeutics Revenue Market Share by Type (2016-2021)
Figure 19. Global Moderate To Severe Acne Therapeutics Revenue Market Share by Type (2022-2027)
Figure 20. North America Moderate To Severe Acne Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Moderate To Severe Acne Therapeutics Market Share by Type (2016-2027)
Figure 22. North America Moderate To Severe Acne Therapeutics Market Share by Application (2016-2027)
Figure 23. North America Moderate To Severe Acne Therapeutics Market Share by Country (2016-2027)
Figure 24. United States Moderate To Severe Acne Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Moderate To Severe Acne Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Moderate To Severe Acne Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Moderate To Severe Acne Therapeutics Market Share by Type (2016-2027)
Figure 28. Europe Moderate To Severe Acne Therapeutics Market Share by Application (2016-2027)
Figure 29. Europe Moderate To Severe Acne Therapeutics Market Share by Country (2016-2027)
Figure 30. Germany Moderate To Severe Acne Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Moderate To Severe Acne Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Moderate To Severe Acne Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Moderate To Severe Acne Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Moderate To Severe Acne Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Moderate To Severe Acne Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Moderate To Severe Acne Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Moderate To Severe Acne Therapeutics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Moderate To Severe Acne Therapeutics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Moderate To Severe Acne Therapeutics Market Share by Region (2016-2027)
Figure 40. China Moderate To Severe Acne Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Moderate To Severe Acne Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Moderate To Severe Acne Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Moderate To Severe Acne Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Moderate To Severe Acne Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Moderate To Severe Acne Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Moderate To Severe Acne Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Moderate To Severe Acne Therapeutics Market Share by Type (2016-2027)
Figure 48. Latin America Moderate To Severe Acne Therapeutics Market Share by Application (2016-2027)
Figure 49. Latin America Moderate To Severe Acne Therapeutics Market Share by Country (2016-2027)
Figure 50. Mexico Moderate To Severe Acne Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Moderate To Severe Acne Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Moderate To Severe Acne Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Moderate To Severe Acne Therapeutics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Moderate To Severe Acne Therapeutics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Moderate To Severe Acne Therapeutics Market Share by Country (2016-2027)
Figure 56. Turkey Moderate To Severe Acne Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Moderate To Severe Acne Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Moderate To Severe Acne Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Allergan Revenue Growth Rate in Moderate To Severe Acne Therapeutics Business (2016-2021)
Figure 60. Bausch Health Revenue Growth Rate in Moderate To Severe Acne Therapeutics Business (2016-2021)
Figure 61. Cipher Pharmaceuticals Revenue Growth Rate in Moderate To Severe Acne Therapeutics Business (2016-2021)
Figure 62. Bayer Revenue Growth Rate in Moderate To Severe Acne Therapeutics Business (2016-2021)
Figure 63. Pfizer Revenue Growth Rate in Moderate To Severe Acne Therapeutics Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Moderate To Severe Acne Therapeutics Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4854 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、重症急性呼吸器症候群（SARS）治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（CEL-1000、D-3252、FDX-000、INO-4500、LCA-60、その他）、用途別市場規模（病院、ク...

世界の脾腫治療薬市場規模・現状・予測（2021年-2027年）

Global Splenomegaly Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-6019 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、脾腫治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物療法、予防接種、その他）、用途別市場規模（正常（非脾腫）、中等度脾腫、重度脾腫）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の局所にきび治療市場規模・現状・予測（2021年-2027年）

Global Topical Use Acne Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4964 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、局所にきび治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（処方箋、OTC）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界の嚢胞性にきび治療市場規模・現状・予測（2021年-2027年）

Global Cystic Acne Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4089 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、嚢胞性にきび治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（局所薬、レーザー治療、マイクロダーマブレーション、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、...

世界の皮膚科処方薬市場規模・現状・予測（2021年-2027年）

Global Prescription Dermatology Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4760 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、皮膚科処方薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（真菌感染症薬、皮膚がん薬、にきび＆酒皶薬、乾癬薬、皮膚炎＆脂漏症薬）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規...

世界のCOPD治療薬市場規模・現状・予測（2021年-2027年）

Global COPD Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5676 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、COPD治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（気管支拡張薬、吸入コルチコステロイド、その他）、用途別市場規模（大人用、子供用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の未分化甲状腺がん治療薬市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-3802 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界のアテローム性動脈硬化症治療薬市場規模・現状・予測（2021年-2027年）

Global Atherosclerosis Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5602 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、アテローム性動脈硬化症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（小分子、生物製剤）、用途別市場規模（病院、診療所、研究機関、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界のアトピー性皮膚炎治療薬市場規模・現状・予測（2021年-2027年）

Global Atopic Dermatitis Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-3867 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、アトピー性皮膚炎治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（外用剤、全身療法）、用途別市場規模（大人用、子供用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、...

世界の抗菌治療薬市場規模・現状・予測（2021年-2027年）

Global Antimicrobial Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5586 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、抗菌治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（病院、診療所、個人、その他）、用途別市場規模（抗ウイルス剤、抗菌剤、抗真菌剤、駆虫剤）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界の重症急性呼吸器症候群（SARS）治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Market The global Severe Acute Respiratory Syndrome(SARS) Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-sta…
世界の光線力学療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Photodynamic Therapy Market The global Photodynamic Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report m…
世界の脾腫治療薬市場規模・現状・予測（2021年-2027年） Splenomegaly is an enlargement of the spleen.The spleen usually lies in the left upper quadrant (LUQ) of the human abdomen. Splenomegaly is one of the four cardinal signs of hypersplenism which include: some reduction in number of circulating blood cells affecting granulocytes, erythrocytes or plate…
世界の長寿＆老化防止治療市場規模・現状・予測（2021年-2027年） Aging is a natural process, yixue anti-aging, refers to some with inhibition, delay the aging process of the body, can promote the overall health, make the body in the genetic factors within the life limit to maintain a better intelligence and physical strength.Aging, however much you may be relucta…
世界の遺伝性遺伝性疾患用遺伝子治療市場規模・現状・予測（2021年-2027年） In the medicine field gene therapy (also called human gene transfer) is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease.A genetic disorder is a genetic problem caused by one or more abnormalities formed in the genome. Gene therapy has the potential to cure …